Gilead Sciences-inc

Showing of 1 - 20 from 4 results
Gilead Sciences-inc - Total results - 4
Cipla's remdevisir to cost Rs 4,000 per 100 mg vial in India; pricing among lowest globally: Report
science

Cipla's remdevisir to cost Rs 4,000 per 100 mg vial in India; pricing among lowest globally: Report

Cipla India business chief executive officer Nikhil Chopra said that the company was launching Cipremi commercially on Wednesday and aims to supply over 80,000 vials within the first month, but did not give details on pricing.

COVID-19 Treatment: Gilead to start testing inhalable form of remdesivir in 60 non-hospitalised patients
science

COVID-19 Treatment: Gilead to start testing inhalable form of remdesivir in 60 non-hospitalised patients

With inhaled remdesivir, Gilead is hoping to target the disease at the onset by delivering the drug directly to the primary site of infection.

Donald Trump defends use of anti-malaria drug hydroxychloroquine as 'line of defence' against coronavirus
World

Donald Trump defends use of anti-malaria drug hydroxychloroquine as 'line of defence' against coronavirus

After Trump's repeated touting of hydroxychloroquine as a 'game-changer' cure for the virus, the FDA issued an advisory warning that the drug has not been 'shown to be safe and effective for treating or preventing COVID-19.'

Despite FDA warning, Donald Trump claims to have been taking hydroxychloroquine for past week to prevent against COVID-19
World

Despite FDA warning, Donald Trump claims to have been taking hydroxychloroquine for past week to prevent against COVID-19

US President Donald Trump, in a surprise announcement, said on Monday he is taking hydroxychloroquine as preventive medicine against the coronavirus despite medical warnings about the use of the malaria drug.